Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
- PMID: 28356719
- PMCID: PMC5367774
- DOI: 10.2147/DDDT.S107195
Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria
Abstract
Antibiotic-resistant bacteria present a great threat to public health. In this study, the synergistic effects of antimicrobial peptides (AMPs) and antibiotics on several multidrug-resistant bacterial strains were studied, and their synergistic effects on azithromycin (AZT)-resistance genes were analyzed to determine the relationships between antimicrobial resistance and these synergistic effects. A checkerboard method was used to evaluate the synergistic effects of AMPs (DP7 and CLS001) and several antibiotics (gentamicin, vancomycin [VAN], AZT, and amoxicillin) on clinical bacterial strains (Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, and Escherichia coli). The AZT-resistance genes (ermA, ermB, ermC, mefA, and msrA) were identified in the resistant strains using quantitative polymerase chain reaction. For all the clinical isolates tested that were resistant to different antibiotics, DP7 had high antimicrobial activity (≤32 mg/L). When DP7 was combined with VAN or AZT, the effect was most frequently synergistic. When we studied the resistance genes of the AZT-resistant isolates, the synergistic effect of DP7-AZT occurred most frequently in highly resistant strains or strains carrying more than two AZT-resistance genes. A transmission electron microscopic analysis of the S. aureus strain synergistically affected by DP7-AZT showed no noteworthy morphological changes, suggesting that a molecular-level mechanism plays an important role in the synergistic action of DP7-AZT. AMP DP7 plus the antibiotic AZT or VAN is more effective, especially against highly antibiotic-resistant strains.
Keywords: antimicrobial peptide; drug synergy; resistant bacteria.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures

Similar articles
-
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.J Pept Sci. 2017 Apr;23(4):329-333. doi: 10.1002/psc.2978. Epub 2017 Feb 8. J Pept Sci. 2017. PMID: 28176481
-
Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.Probiotics Antimicrob Proteins. 2024 Jun;16(3):796-814. doi: 10.1007/s12602-023-10070-w. Epub 2023 May 6. Probiotics Antimicrob Proteins. 2024. PMID: 37148452
-
Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.BMC Microbiol. 2016 Aug 19;16(1):189. doi: 10.1186/s12866-016-0799-z. BMC Microbiol. 2016. PMID: 27542832 Free PMC article.
-
Antimicrobial peptides: new hope in the war against multidrug resistance.Zool Res. 2019 Nov 18;40(6):488-505. doi: 10.24272/j.issn.2095-8137.2019.062. Zool Res. 2019. PMID: 31592585 Free PMC article. Review.
-
Antimicrobial peptides: evolving soldiers in the battle against drug-resistant superbugs.Mol Biol Rep. 2025 Apr 28;52(1):432. doi: 10.1007/s11033-025-10533-z. Mol Biol Rep. 2025. PMID: 40293554 Review.
Cited by
-
Broad-Spectrum Antimicrobial Activity and Improved Stability of a D-Amino Acid Enantiomer of DMPC-10A, the Designed Derivative of Dermaseptin Truncates.Antibiotics (Basel). 2020 Sep 21;9(9):627. doi: 10.3390/antibiotics9090627. Antibiotics (Basel). 2020. PMID: 32967333 Free PMC article.
-
Investigation on the Synergy between Membrane Permeabilizing Amphiphilic α-Hydrazido Acids and Commonly Used Antibiotics against Drug-Resistant Bacteria.Molecules. 2024 Aug 28;29(17):4078. doi: 10.3390/molecules29174078. Molecules. 2024. PMID: 39274926 Free PMC article.
-
Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Staphylococcus aureus Strains: Classification, Structures, and Mechanisms of Action.Int J Mol Sci. 2021 Jul 25;22(15):7927. doi: 10.3390/ijms22157927. Int J Mol Sci. 2021. PMID: 34360692 Free PMC article. Review.
-
Host Defense Peptide Piscidin and Yeast-Derived Glycolipid Exhibit Synergistic Antimicrobial Action through Concerted Interactions with Membranes.JACS Au. 2023 Oct 19;3(12):3345-3365. doi: 10.1021/jacsau.3c00506. eCollection 2023 Dec 25. JACS Au. 2023. PMID: 38155643 Free PMC article.
-
WLBU2 Antimicrobial Peptide as a Potential Therapeutic for Treatment of Resistant Bacterial.Turk J Pharm Sci. 2022 Feb 28;19(1):110-116. doi: 10.4274/tjps.galenos.2020.43078. Turk J Pharm Sci. 2022. PMID: 35227034 Free PMC article.
References
-
- Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol. 2014;12(7):465–478. - PubMed
-
- Livermore DM, Warner M, Mushtaq S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother. 2013;68(10):2286–2290. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical